Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Headquartered in Munich, privately held Tubulis has developed next-generation AD...
Using this new platform, researchers developed a covalent antagonist targeting P...
Soleno finished 2025 with $190.4 million in net revenue from sales of Vykat. Neu...
A new class of drug compounds reduce harmful inflammation while maintaining the ...
Microplastics were found in each of the human bile samples examined, showing tha...
Researchers developed a blood test that, in early studies in more than 1,000 peo...
A new metabolic mechanism describes how tumors disable immune “gatekeeper” in th...
In the first of a new series of GEN Keynote Webinars, Professor Rodolphe Barrang...
The collaboration brings together OneCyte's proprietary single-cell platform for...
Strong intellectual property protections sustain biotechnology innovation by ena...
Researchers confirmed that cytoplasmic contents could be extracted in a pressure...
Trung Huynh, an analyst with RBC Capital Markets, has projected Foundayo will re...
Researchers developed an injectable hemostatic microgel to help reduce bleeding ...
By combining CRISPR screening with epigenetic targeting, scientists identified a...
GATC Health says that an AI-driven in silico multi-omics approach shaves time of...
The team engineered vertical micropillars—each tens of times thinner than a huma...
